Skip to main content
Premium Trial:

Request an Annual Quote

Syntegra Teams With Vanderbilt's Nashville Biosciences on Biobank Data Analysis for Drug R&D

NEW YORK – Biomedical informatics vendor Syntegra said Tuesday that it is collaborating with Nashville Biosciences in an attempt to accelerate drug discovery and development.

San Francisco-based Syntegra, maker of a machine-learning platform called Syntegra Medical Mind, will work with Vanderbilt University Medical Center subsidiary Nashville Biosciences to produce synthetic populations using data from VUMC's BioVU biorepository. They initially will attempt to utilize the synthetic data to recreate a recent study comparing the performance of different treatments for type 2 diabetes.

"The Syntegra Medical Mind works by extracting patterns of care within real data, and then creating a complete replica dataset," Syntegra Cofounder and Chief Technology Officer Ofer Mendelevitch said in a statement.

Syntegra Cofounder and CEO Michael Lesh explained that working with synthetic data removes the privacy risk associated with using real-world data. "Synthetic data will unlock opportunities to dramatically accelerate how life-saving treatments reach patients," he said.

Nashville Biosciences, sometimes called NashBio, was spun out of Vanderbilt in 2018 to offer services and technology to the pharmaceutical and diagnostics industries based on data from BioVU, a biobank containing millions of longitudinal medical records with hundreds of thousands of linked genetic samples.

"We are constantly looking for innovative new tools and approaches that we can deploy against our clients' R&D problems," said Leeland Ekstrom, COO and cofounder of Nashville Biosciences. "The Syntegra Medical Mind is an analytic approach that does exactly that, and we are excited to test it in this specific application."

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.